From: Emergence of HBV resistance to lamivudine (3TC) in HIV/HBV co-infected patients in The Gambia, West Africa
Patient ID
3TC Mutations
Time after initiation of LMV therapy (months)
Patient 6
M204V
L180M
25
Patient 12
V173L*
16
Patient 13
36